Levoketoconazole and Brigatinib: Interaction Details
- Brigatinib
- Alunbrig
- Levoketoconazole
- Recorlev
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Levoketoconazole and Brigatinib interaction:
Levoketoconazole
- Recorlev
What Happens When You Take Levoketoconazole With Brigatinib
What can happen when they are taken together (rated Contraindicated)
Increased exposure and an increased risk of sensitive CYP3A4 substrate-related adverse reaction
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Levoketoconazole must not be given together with sensitive CYP3A4 substrates, as this combination is . Because levoketoconazole inhibits CYP3A4, using it alongside a sensitive CYP3A4 substrate can raise exposure to that substrate and may heighten the risk of adverse reactions associated with it. A drug interaction study of levoketoconazole 400 mg once daily given with felodipine, a sensitive CYP3A4 substrate, showed increases in felodipine of 1007% and in of 937%.1
The Levoketoconazole and Brigatinib Interaction, Explained
These two medicines should not be taken together. Levoketoconazole (Recorlev) slows down an enzyme in your liver called , which helps clear brigatinib (Alunbrig) from your body. With less clearing, brigatinib can build up, which may raise the chance of side effects such as lung problems (cough, trouble breathing), high blood pressure, slow heartbeat, vision changes, or muscle pain.
The strongest data come from a similar drug study, where a different medicine cleared by the same enzyme rose about tenfold. Please do not stop or change either medicine on your own. Talk with your pharmacist or doctor, who can review your options and manage this safely.
Mechanism: Levoketoconazole is a strong . Brigatinib is a CYP3A4 (and its depends substantially on CYP3A4), so is expected to increase brigatinib exposure (, ). Neither drug's activity depends on activation.
- Direction: increased substrate exposure and risk of concentration-related adverse reactions (e.g., ILD/pneumonitis, hypertension, , visual disturbance, CPK elevation, pancreatic enzyme elevation).
- Magnitude: not studied with brigatinib specifically; with felodipine (sensitive substrate), AUC rose 1007% and Cmax 937%.
- Onset: unspecified. Evidence: probable. Severity: per labeling.
- Management: avoid ; review for an alternative to one agent with the prescriber.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Levoketoconazole and Brigatinib Interact
The likely mechanism
of -substrate by levoketoconazole
How to Manage the Levoketoconazole and Brigatinib Interaction
The documented guidance is that these medicines are not to be used together, so the main step is for your care team to review your regimen.
- Keep taking your medicines as prescribed until you speak with your prescriber or pharmacist. Do not stop either one on your own.
- Tell every prescriber and pharmacist that you take both brigatinib and levoketoconazole.
- Your care team may discuss choosing an alternative for one of the medicines.
- Report new or worsening cough, shortness of breath, dizziness, slow heartbeat, vision changes, or muscle pain promptly.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Levoketoconazole or Brigatinib need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Prescribing information: RECORLEV oral tablets, levoketoconazole oral tablets
In a drug interaction study (N=14), levoketoconazole 400 mg once daily given together with felodipine (a sensitive ) raised felodipine by 1007% and by 937%, relative to felodipine given alone.1
Levoketoconazole and Brigatinib: Common Questions
How serious is the Levoketoconazole and Brigatinib interaction?
It is rated . These should generally not be used together.
How is the Levoketoconazole and Brigatinib interaction managed?
The documented guidance is that these medicines are not to be used together, so the main step is for your care team to review your regimen. Keep taking your medicines as prescribed until you speak with your prescriber or pharmacist. Do not stop either one on your own. Tell every prescriber and pharmacist that you take both brigatinib and levoketoconazole. Your care team may discuss choosing an alt… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Levoketoconazole and Brigatinib Interaction
Ask in your own words about taking Levoketoconazole and Brigatinib together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Product Information: RECORLEV(R) oral tablets, levoketoconazole oral tablets. Xeris Pharmaceuticals Inc (per FDA), Chicago, IL, 2023. DailyMed
Other Serious Interactions of Levoketoconazole and Brigatinib
Also serious with Brigatinib
- RanolazineContraindicated
- Mifepristone (Korlym)Contraindicated
- Mifepristone (Mifeprex)Contraindicated
- RelugolixMajor
Also serious with Levoketoconazole
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Brigatinib
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- Vitamin EModerate
- GingerModerate
- TurmericModerate
- Black PepperModerate
- GrapeModerate
- + 140 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together. This interaction.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.